CG
FBRX icon

Cutler Group’s Forte Biosciences FBRX Stock Holding History

Cutler Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-159
Closed -$3K – 2664
2023
Q4 		$3K Hold
159
– – ﹤0.01% 2945
2023
Q3 		$2K Hold
159
– – ﹤0.01% 3247
2023
Q2 		$4K Hold
159
– – ﹤0.01% 2704
2023
Q1 		$4K Hold
159
– – ﹤0.01% 2817
2022
Q4 		$3K Sell
159
-16
-9% -$410 ﹤0.01% 3465
2022
Q3 		$4K Hold
175
– – ﹤0.01% 3770
2022
Q2 		$5K Hold
175
– – ﹤0.01% 3693
2022
Q1 		$6K Sell
175
-84
-32% -$3.18K ﹤0.01% 3994
2021
Q4 		$13K Sell
259
-379
-59% -$25.5K ﹤0.01% 3479
2021
Q3 		$47K Buy
+638
New +$353K ﹤0.01% 2553

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cutler Group's FBRX Position: Q1 2024 in Review

Cutler Group sold out of Forte Biosciences (FBRX) in Q1 2024, closing a stake of 159 shares — an estimated $3K sold.

Cutler Group first reported a position in FBRX in Q3 2021 and held it in 10 quarters. The position peaked at $47K in Q3 2021. 32 funds tracked by Wall St. Rank hold FBRX as of Q1 2024.

  • Cutler Group reported no remaining Forte Biosciences position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 159 Forte Biosciences shares in Q1 2024, an estimated $3K.
  • Cutler Group first reported a position in Forte Biosciences in Q3 2021 and held it in 10 quarters.
  • Cutler Group's Forte Biosciences position peaked at $47K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.